Short-term Effects of Inhaled β-Adrenergic Agonist on Breathlessness and Central Inspiratory Drive in Patients With Nonreversible COPD
- 1 September 1996
- Vol. 110 (3) , 637-641
- https://doi.org/10.1378/chest.110.3.637
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Changing Practices in COPDChest, 1995
- The Relationship Between Pulmonary Function and Dyspnea in Obstructive Lung DiseaseChest, 1989
- A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exerciseClinical Science, 1989
- Effect of Inhaled Metaproterenol on Exercise Performance in Patients with Stable “Fixed” Airway ObstructionAmerican Review of Respiratory Disease, 1988
- Comparison of Clinical Dyspnea Ratings and Psychophysical Measurements of Respiratory Sensation in Obstructive Airway Disease1–4American Review of Respiratory Disease, 1987
- Efficacy of Inhaled Metaproterenol and Orally-administered Theophylline in Patients with Chronic Airflow ObstructionChest, 1986
- Effects of Beta-Agonists on Breathlessness and Exercise Tolerance in Patients with Chronic Obstructive Pulmonary DiseaseRespiration, 1986
- Assessment and Management of BreathlessnessChest, 1985
- Effect of increased lung volume on perception of breathlessness, effort, and tensionJournal of Applied Physiology, 1984
- Physiologic Effects of Oral Bronchodilators during Rest and Exercise in Chronic Obstructive Pulmonary DiseaseChest, 1983